[
  {
    "ts": "2025-12-08T14:00:00+00:00",
    "headline": "Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy",
    "summary": "Technology uses real-world sleep data and machine learning to help people with sleep apnea start and stay on therapySAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has received U.S. Food and Drug Administration (FDA) clearance for Personalized Therapy Comfort Settings (PTCS), to be marketed as Smart Comfort. Smart Comfort is the first FDA-cleared AI-enab",
    "url": "https://finance.yahoo.com/news/resmed-receives-fda-clearance-personalized-140000575.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "f14d22bd-1d75-3bb4-8213-77012fbaf5b0",
      "content": {
        "id": "f14d22bd-1d75-3bb4-8213-77012fbaf5b0",
        "contentType": "STORY",
        "title": "Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy",
        "description": "",
        "summary": "Technology uses real-world sleep data and machine learning to help people with sleep apnea start and stay on therapySAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has received U.S. Food and Drug Administration (FDA) clearance for Personalized Therapy Comfort Settings (PTCS), to be marketed as Smart Comfort. Smart Comfort is the first FDA-cleared AI-enab",
        "pubDate": "2025-12-08T14:00:00Z",
        "displayTime": "2025-12-08T14:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/dea44210d8c42564e1f27e13fba486ae",
          "originalWidth": 1182,
          "originalHeight": 247,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3W0YPXC5YT.K3LOSdX34Sw--~B/aD0yNDc7dz0xMTgyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/dea44210d8c42564e1f27e13fba486ae.cf.webp",
              "width": 1182,
              "height": 247,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FSnpDKdN2e2mL..bKPxyOw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/dea44210d8c42564e1f27e13fba486ae.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/resmed-receives-fda-clearance-personalized-140000575.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/resmed-receives-fda-clearance-personalized-140000575.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "RMD"
            },
            {
              "symbol": "RSMDF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]